News & Articles

the In silico analysis of lineage B.1.1.529 (Omicron) is applicable to the VIASURE range of products

Discover the latest resources and innovative tools driving immuno-oncology research forward

Discover insights on topics from lab automation and gene therapy to monoclonal antibodies and clinical diagnostics

Company testing three existing COVID-19 vaccine booster candidates against the Omicron variant

Data are now available from all enrolled participants

A true walk away ‘sample to answer’ molecular diagnostic system designed for high throughput testing, offering a time-efficient and seamless workflow for clinical laboratories

The assays have shown efficacy against the newest variants of concern

NeuroSphere Virtual Clinic utilizes advancements in digital technology to optimize care for patients with chronic pain or movement disorders

Dr. Martin Than shares how adoption of POC assays could enable rapid decision making, to help tackle overcrowding issues in emergency settings

Making the most of agrigenomic expertise and existing technologies to enable a rapid response to the pandemic

Explore cutting-edge technologies, free downloads, and expert insight to support your research

Testing positive on a COVID-19 PCR test has been shown to have a positive correlation to mental illness and sleep problems

New testing capacity complements EKF’s test kit manufacturing and point-of-care diagnostic instrument business

Discover insights on topics from lab automation and drug development to clinical LC-MS/MS and point-of-care testing

the VOYAGER pipette range is generating more data in less time for HIV researchers

Dr. Michael Samoszuk discusses the benefits of high-sensitivity cardiac troponin POC assays and shares his views on how they will be positioned in future healthcare settings

The first patients have been enrolled in this trial to help treatment for Amyotrophic Lateral Sclerosis (ALS)

Hear from leading experts and explore tools to advance your work using 3D cell culture

The innovative technique can offer a more effective approach to radiotherapy

The new facilities are designed to enable IVD and point of care businesses to develop and manufacture assays at scale

DAPA-CKD Phase III trial sub-analyses showed that kidney and cardiovascular outcomes were consistent